IN2015DN03980A - - Google Patents
Info
- Publication number
- IN2015DN03980A IN2015DN03980A IN3980DEN2015A IN2015DN03980A IN 2015DN03980 A IN2015DN03980 A IN 2015DN03980A IN 3980DEN2015 A IN3980DEN2015 A IN 3980DEN2015A IN 2015DN03980 A IN2015DN03980 A IN 2015DN03980A
- Authority
- IN
- India
- Prior art keywords
- purification
- contrast agents
- relates
- ray contrast
- ioforminol
- Prior art date
Links
- 239000002872 contrast media Substances 0.000 abstract 3
- 238000000746 purification Methods 0.000 abstract 3
- BFVVDRUCXCIALU-UHFFFAOYSA-N 5-[[3-[3,5-bis(2,3-dihydroxypropylcarbamoyl)-n-formyl-2,4,6-triiodoanilino]-2-hydroxypropyl]-formylamino]-1-n,3-n-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound OCC(O)CNC(=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(N(CC(O)CN(C=O)C=2C(=C(C(=O)NCC(O)CO)C(I)=C(C(=O)NCC(O)CO)C=2I)I)C=O)=C1I BFVVDRUCXCIALU-UHFFFAOYSA-N 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 abstract 1
- 229960004359 iodixanol Drugs 0.000 abstract 1
- 229950004332 ioforminol Drugs 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12198020 | 2012-12-19 | ||
| PCT/US2013/070699 WO2014099214A1 (en) | 2012-12-19 | 2013-11-19 | Purification of x-ray contrast agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN03980A true IN2015DN03980A (el) | 2015-10-02 |
Family
ID=47458704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3980DEN2015 IN2015DN03980A (el) | 2012-12-19 | 2013-11-19 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9938233B2 (el) |
| EP (1) | EP2935204B1 (el) |
| JP (2) | JP6342421B2 (el) |
| KR (1) | KR102180250B1 (el) |
| CN (1) | CN104854080B (el) |
| AU (1) | AU2013364113B2 (el) |
| CA (1) | CA2890449C (el) |
| ES (1) | ES2690128T3 (el) |
| HU (1) | HUE039458T2 (el) |
| IN (1) | IN2015DN03980A (el) |
| NZ (1) | NZ708503A (el) |
| PL (1) | PL2935204T3 (el) |
| RU (1) | RU2662941C2 (el) |
| SG (1) | SG11201504201RA (el) |
| WO (1) | WO2014099214A1 (el) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201504201RA (en) | 2012-12-19 | 2015-07-30 | Ge Healthcare As | Purification of x-ray contrast agents |
| KR101699539B1 (ko) * | 2015-12-30 | 2017-02-13 | (주)솔레이어 | 나노 여과 모듈 및 이를 이용한 농축 방법 |
| CN113121377A (zh) * | 2019-12-31 | 2021-07-16 | 江苏汉邦科技有限公司 | 碘克沙醇的纯化方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5447635A (en) * | 1991-02-26 | 1995-09-05 | Bracco International B.V. | Process of concentration and purification of organic compounds |
| IT1248741B (it) | 1991-02-26 | 1995-01-26 | Bracco Spa | Processo di concentrazione e di purificazione di composti organici |
| US5221485A (en) | 1991-12-03 | 1993-06-22 | Mallinckrodt Medical, Inc. | Purification of X-ray contrast agent, magnetic resonance imaging agent, or radiopharmaceuticals using reverse osmosis |
| DE69416015D1 (de) * | 1993-02-26 | 1999-03-04 | Createrra Inc | Verfahren zur Herstellung von Substanzen zur Reinigung von Wasser |
| IL110391A (en) | 1993-07-30 | 1998-12-06 | Zambon Spa | Process for the formation of infamidol |
| US5811581A (en) | 1994-08-04 | 1998-09-22 | Dibra S.P.A. | Process for the purification of opacifying contrast agents |
| IT1282674B1 (it) | 1996-02-23 | 1998-03-31 | Bracco Spa | Processo per la purificazione di agenti contrastografici opacizzanti |
| US6425885B1 (en) | 1999-12-20 | 2002-07-30 | Ultradent Products, Inc. | Hydraulic syringe |
| NO20043305D0 (no) | 2004-08-09 | 2004-08-09 | Amersham Health As | Preparation of lodixanol |
| NO20053676D0 (no) * | 2005-07-29 | 2005-07-29 | Amersham Health As | Crystallisation Process |
| NO20055643D0 (no) | 2005-11-29 | 2005-11-29 | Amersham Health As | Preparation of lodixanol |
| ES2486296T3 (es) | 2007-07-12 | 2014-08-18 | Ge Healthcare As | Agentes de contraste |
| US8445725B2 (en) * | 2008-01-14 | 2013-05-21 | Mallinckrodt Llc | Process for the preparation of iosimenol |
| US20110021823A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Processing crude iodixanol mixture by nanofiltration |
| AU2009355814B2 (en) * | 2009-11-26 | 2016-06-30 | Imax Diagnostic Imaging Holding Ltd | Preparation and purification of iodixanol |
| ES2680019T3 (es) | 2010-12-21 | 2018-09-03 | Ge Healthcare As | Desalinización de una composición que comprende un agente de contraste |
| SG11201504201RA (en) | 2012-12-19 | 2015-07-30 | Ge Healthcare As | Purification of x-ray contrast agents |
-
2013
- 2013-11-19 SG SG11201504201RA patent/SG11201504201RA/en unknown
- 2013-11-19 AU AU2013364113A patent/AU2013364113B2/en active Active
- 2013-11-19 WO PCT/US2013/070699 patent/WO2014099214A1/en active Application Filing
- 2013-11-19 RU RU2015121502A patent/RU2662941C2/ru active
- 2013-11-19 KR KR1020157015950A patent/KR102180250B1/ko active IP Right Grant
- 2013-11-19 NZ NZ708503A patent/NZ708503A/en unknown
- 2013-11-19 US US14/442,203 patent/US9938233B2/en active Active
- 2013-11-19 ES ES13864437.2T patent/ES2690128T3/es active Active
- 2013-11-19 EP EP13864437.2A patent/EP2935204B1/en active Active
- 2013-11-19 CN CN201380066485.8A patent/CN104854080B/zh active Active
- 2013-11-19 HU HUE13864437A patent/HUE039458T2/hu unknown
- 2013-11-19 PL PL13864437T patent/PL2935204T3/pl unknown
- 2013-11-19 CA CA2890449A patent/CA2890449C/en active Active
- 2013-11-19 JP JP2015549398A patent/JP6342421B2/ja active Active
- 2013-11-19 IN IN3980DEN2015 patent/IN2015DN03980A/en unknown
-
2018
- 2018-03-26 JP JP2018057348A patent/JP2018115193A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016503054A (ja) | 2016-02-01 |
| EP2935204A4 (en) | 2016-08-17 |
| RU2662941C2 (ru) | 2018-07-31 |
| EP2935204B1 (en) | 2018-09-05 |
| ES2690128T3 (es) | 2018-11-19 |
| US9938233B2 (en) | 2018-04-10 |
| CA2890449A1 (en) | 2014-06-26 |
| NZ708503A (en) | 2019-08-30 |
| CN104854080B (zh) | 2018-07-03 |
| AU2013364113B2 (en) | 2018-01-18 |
| CA2890449C (en) | 2020-12-29 |
| EP2935204A1 (en) | 2015-10-28 |
| KR20150094639A (ko) | 2015-08-19 |
| PL2935204T3 (pl) | 2018-12-31 |
| SG11201504201RA (en) | 2015-07-30 |
| JP6342421B2 (ja) | 2018-06-13 |
| KR102180250B1 (ko) | 2020-11-18 |
| RU2015121502A (ru) | 2017-01-26 |
| CN104854080A (zh) | 2015-08-19 |
| JP2018115193A (ja) | 2018-07-26 |
| HUE039458T2 (hu) | 2019-01-28 |
| WO2014099214A1 (en) | 2014-06-26 |
| US20160304440A1 (en) | 2016-10-20 |
| AU2013364113A1 (en) | 2015-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201804869UA (en) | Purification of biological molecules | |
| IN2014DN08481A (el) | ||
| EP2850110A4 (en) | COMPOSITIONS CONTAINING PURIFIED NON-HEVEA RUBBER AND METHODS OF PURIFICATION THEREFOR | |
| NZ704662A (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
| MX2019011905A (es) | Nuevas composiciones para el tratamiento de la esclerosis lateral amiotrofica. | |
| MX2012007710A (es) | Alfa-amilasas. | |
| MX2013009175A (es) | Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas. | |
| MX2013004338A (es) | Secuencias de repeticiones palindromicas cortas separadas regularmente agrupadas-cas (crisp-cas). | |
| MX347165B (es) | Composicion efervescente en forma solida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales. | |
| EP2867193A4 (en) | PROCESS FOR REDUCING RFCCX CONTAMINATION IN FLUOROLEFINES | |
| PL2425721T3 (pl) | Sposób oczyszczania wysokiej czystości mogrozydów | |
| MX2013000793A (es) | Composicion que contiene galacto-oligosacarido y un metodo para producirla. | |
| PL2922893T3 (pl) | Kompozycje utwardzane wilgocią, sposób ich wytwarzania i ich zastosowania | |
| IN2012MU03723A (el) | ||
| IN2014DN08412A (el) | ||
| IN2015DN01811A (el) | ||
| MX349224B (es) | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa. | |
| IN2015DN02292A (el) | ||
| IN2015KN00073A (el) | ||
| EP2580342A4 (en) | COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID USED FOR STRONG PURIFICATIONS | |
| IN2014DN03298A (el) | ||
| IL232735A (en) | Process for the purification of polyaminocarboxylates | |
| MX362340B (es) | Preparacion de intermediarios de agentes de contraste de rayos x. | |
| IN2015DN03980A (el) | ||
| MX2015003034A (es) | Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso. |